Clinical Trial Update: A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated GSK256073 in adults with Type 2 diabetes mellitus treated with metformin, and the study has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK256073

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2017-10-11